Health TidingsZorevunersen Shows Sustained Seizure and Neurodevelopment Benefits Through ... Zorevunersen Shows Sustained Seizure and Neurodevelopment Benefits Through ... Read Post »
Health TidingsAlumis’ Envudeucitinib Misses LUMUS SLE Endpoints, Shows Promise in IFNGS... Alumis’ Envudeucitinib Misses LUMUS SLE Endpoints, Shows Promise in IFNGS... Read Post »
Health TidingsGSK’s mRNA Flu Vaccine Shows Stronger Immune Responses, Moves to Phase II... GSK’s mRNA Flu Vaccine Shows Stronger Immune Responses, Moves to Phase II... Read Post »
New Drug ApprovalEnhertu Plus Pertuzumab Wins EU Approval After Strong Phase III Results Enhertu Plus Pertuzumab Wins EU Approval After Strong Phase III Results Read Post »
Clinical TrialsNovartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Novartis Remibrutinib Shows Strong Phase 3 Results in Multiple Sclerosis Read Post »
Clinical TrialsTagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Tagrisso Plus Orpathys Improves Progression-Free Survival in First-Line MET... Read Post »
Health TidingsChiesi Fabry Data Reveal Monitoring Gaps and New Four-Week Elfabrio Experie... Chiesi Fabry Data Reveal Monitoring Gaps and New Four-Week Elfabrio Experie... Read Post »
Clinical TrialsNirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Nirmatrelvir–Ritonavir Fails to Improve Long COVID in Large Phase 2 RECOV... Read Post »
Health TidingsFDA Aligns on Phase 3 Endpoint for Cadrenal’s 12-LOX Inhibitor in Heparin... FDA Aligns on Phase 3 Endpoint for Cadrenal’s 12-LOX Inhibitor in Heparin... Read Post »
FoodKetogenic Diet Linked to Better Liver Health and Blood Sugar Control After ... Ketogenic Diet Linked to Better Liver Health and Blood Sugar Control After ... Read Post »
Clinical TrialsArrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Arrowhead’s Plozasiran Cuts Triglycerides Up to 81% and Reduces Pancreati... Read Post »
Clinical TrialsSRD-002 Delivers Sustained 12-Month Improvements in HFpEF SRD-002 Delivers Sustained 12-Month Improvements in HFpEF Read Post »
Health TidingsAskBio Completes GenePHIT Enrollment with Well-Characterized Non-Ischemic H... AskBio Completes GenePHIT Enrollment with Well-Characterized Non-Ischemic H... Read Post »
Clinical TrialsZanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Zanidatamab Plus Chemotherapy Improves Survival in HER2+ GEA Read Post »
Clinical TrialsTaltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Taltz and Zepbound Sustain One-Year Benefits in Psoriatic Disease with Obes... Read Post »
New Drug ApprovalFirst New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval First New ET Treatment in Nearly 30 Years: BESREMi Wins FDA Approval Read Post »
Health TidingsLilly to Acquire Merida Biosciences for Up to $2.875 Billion to Advance Pre... Lilly to Acquire Merida Biosciences for Up to $2.875 Billion to Advance Pre... Read Post »
Clinical TrialsRepatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Repatha Cuts Death Risk in High-Risk Patients Before a First Heart Attack o... Read Post »
Health TidingsKaryopharm Files sNDA for Selinexor Combination in Myelofibrosis Karyopharm Files sNDA for Selinexor Combination in Myelofibrosis Read Post »
Health TidingsSaroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Saroglitazar Hits Primary Endpoint in Zydus’ Phase II(b) MASH Trial Read Post »
Health TidingsTNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss TNX-103 Posts Strong Subgroup Results in PH-HFpEF Despite LEVEL Trial Miss Read Post »
Health TidingsAZD5462 Shows Early Effects in Phase IIb Heart Failure Trial AZD5462 Shows Early Effects in Phase IIb Heart Failure Trial Read Post »
Clinical TrialsNew Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups New Data Reinforce Vutrisiran Benefit Across ATTR-CM Patient Groups Read Post »
Clinical TrialsKey QRX003 Interim Results Reveal Improvement in Netherton Syndrome Key QRX003 Interim Results Reveal Improvement in Netherton Syndrome Read Post »
Clinical TrialsCamzyos Shows Strong Five-Year Results in Patients With oHCM Camzyos Shows Strong Five-Year Results in Patients With oHCM Read Post »
New Drug ApprovalNew Hope for Polycythemia Vera: FDA Approves MIMRYLO New Hope for Polycythemia Vera: FDA Approves MIMRYLO Read Post »
Health TidingsFDA Expands Stelara to Pediatric Ulcerative Colitis FDA Expands Stelara to Pediatric Ulcerative Colitis Read Post »
Clinical TrialsCRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year CRISPR-Cas9 Therapy CTX310 Shows Durable Lipid Lowering Through 1 Year Read Post »
Health TidingsFDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... FDA Approves Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults... Read Post »
Health TidingsBioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues BioNTech Ends Autogene Cevumeran CRC Trial, Pancreatic Trial Continues Read Post »
Health TidingsMBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... MBX Biosciences Starts Phase 3 Trial of Once-Weekly Canvuparatide in Chroni... Read Post »
Clinical TrialsAficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HC... Read Post »
Clinical TrialsMiv-cel CAR T Therapy Shows Promise in Refractory RA Miv-cel CAR T Therapy Shows Promise in Refractory RA Read Post »
New Drug ApprovalFDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... FDA Approves Bixlenvo, First Single-Tablet HIV Regimen for Patients on Comp... Read Post »
Health Tidings Mergers & AcquisitionsDualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... DualityBio, Genentech Strike ADC Deal Worth More Than $1 Billion in Potenti... Read Post »
Health TidingsPfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Pfizer-BioNTech XFG COVID-19 Vaccine Wins FDA Approval Read Post »
Health TidingsSOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma SOT106 Gets FDA Fast Track Designation for Soft Tissue Sarcoma Read Post »
New Drug ApprovalFDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... FDA Approves LISRAYA as First Targeted Oral Therapy for Adults with Dermato... Read Post »
Clinical TrialsPaxalisib Shows Early Clinical Activity in Advanced TNBC Paxalisib Shows Early Clinical Activity in Advanced TNBC Read Post »
New Drug ApprovalModerna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Moderna Secures FDA Approval for XFG-Updated Spikevax and mNEXSPIKE for 202... Read Post »
New Drug ApprovalHUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... HUTCHMED Secures NMPA Conditional Approval for ATLED® (Fanregratinib) in F... Read Post »
Clinical TrialsiECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... iECURE Reports 74% Reduction in Hyperammonemic Crises With ECUR-506 in OTC ... Read Post »
Clinical TrialsCorvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Corvus’ Soquelitinib Shows Durable Activity in T-Cell Lymphoma, Supportin... Read Post »
Health TidingsNatera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Natera, Angiex Expand Signatera ctDNA Monitoring in AGX101 Trial Read Post »
Health TidingsGenerate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Generate Biomedicines Discloses Early Release of Three GB-0895 Posters Ahea... Read Post »
Clinical TrialsPositive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Positive CROSSING Results Expand Tezspire’s Potential in Eosinophilic Eso... Read Post »
Health TidingsAbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease AbbVie Seeks EMA Nod for Subcutaneous SKYRIZI in Crohn’s Disease Read Post »
ResearchStopping Statins After 75: What a New Randomized Trial Found Stopping Statins After 75: What a New Randomized Trial Found Read Post »
Health TidingsGV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... GV101 Shows High Response Rates in Phase Ib/II Study of Chronic Graft-versu... Read Post »
Health TidingsZepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Zepbound Linked to Lower Healthcare Costs in Adults Over Age 55 With Obesit... Read Post »
